홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
EDAP
#3093
EDAP TMS SA
4.3
7
-1.80%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-1.80%
월간 변동
+5.56%
6달 변화
+173.12%
년간 변동율
+65.53%
이전 종가
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
양
2
마켓
주식
헬스케어
EDAP
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.39 M
144.87 M
Valuation ratios
Enterprise value
82.64 M
865.47 M
Price to earnings ratio
-4.33
169.85
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
뉴스
EDAP, 기록적인 HIFU 매출 발표 및 2026년 강력한 전망 제시
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP, Focal One 로봇 HIFU 시스템 FDA 승인 획득
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
EDAP TMS 주가 목표가, Jefferies, $2.00으로 상향 조정
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
EDAP TMS SA Q3 실적, 수익 예상치를 넘어
EDAP earnings beat by €0.08, revenue topped estimates